Please visit our MS learning channel on Youtube, which provides hundreds of topics from our education programs, that were video-recorded and archived here: www.youtube.com/msviewsandnews -- Be empowered with MS news by registering with us: www.register.msviewsandnews.org

joomla ecommerce template -- Scroll left side of this blog for needed resources. Also, use our 'search by topic' tool, to find specific information.

Disclaimer: 'MS Views and News' DOES NOT endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.

============================================================

Wednesday, December 4, 2013

Stu’s Views concerning Lemtrada (Alemtuzumab)

About once a year (maybe more) you actually get to see an article of story written by Stuart known as Stu's Views


Published:  December 4, 2013

Stu’s Views concerning Lemtrada (Alemtuzumab).  


As reported The FDA is having its’ concerns about the approval of Lemtrada (Alemtuzumab).  To read one of these reports, click here.

Now let’s take a different look at this picture because I for one am not happy to read/hear what the FDA might not know with regards to the MS Patient.

Note please: 
It is not that I need this medication. It is not that I am ready to give up on a medication that has been working very successfully for me. -- No, I am looking at the Big Picture.

I am thinking about the thousands for whom current medications have failed to be effective OR that the person’s body failed to accept one of the currently approved MS medications. Yes, there is a difference.

I know many people who need another option. I know and see many whose gait has considerably worsened or whose mind is quite boggled or confused. I have seen too many who walked just a few years ago, but who now require a walker, wheelchair or scooter. I am thinking of those that used to be attorneys, bankers, retail clerks, teachers, Postal carriers and so much more but who now sit home asking themselves, why?

I know many who have given up hope and I know others who still have great hope.

There should be another choice and the only thing currently sitting on the table ready for potential use by some of these people is Lemtrada (Alemtuzumab).  

The FDA needs to hear from the Public.
Heck, they need to see and hear from us. Even if your current medication is working for you, consider what you might be like if the medication you are using, had not been FDA approved? What then? 

Let us help our peers who seek another medication that might enable them to live better, with an option that might thwart or slow their disease progression.

PLEASE let your voice be heard by putting it into writing.  
YOU can voice your thoughts on Alemtuzumab.  

We have learned that the FDA Advisory Committee email address is- PCNS@fda.hhs.gov  
Address your letters to Glendolynn Johnson, who staffs the Peripheral and Central Nervous System Drugs Advisory Committee.

Ask her to make sure that Alemtuzumab for MS gets approved.

It will take a great many people to be heard.
Let’s shout loud.
Let’s be heard.

Let’s help those who need our help in getting another medication option.

AGAIN:::   PLEASE let your voice be heard, by putting it into writing. 


Thank you

Best Regards,

Stuart 
Stu’s Views and MS News



Disclaimer: 
Neither Stu's Views and MS News nor MS Views and News is responsible for the opinion expressed by Stuart.

.


.

No comments: